Distribution of immunoglobulin superfamily members ICAM-1, -2, -3, and the β2 integrin LFA-1 in multiple sclerosis lesions

Journal of Neuropathology and Experimental Neurology

Volumn 55, Issue 10, 1996, Pages 1060-1072

  Bö, Lars ^a   Peterson, John W ^a   Mørk, Sverre ^b   Hoffman, Patricia A ^c   Gallatin, W Michael ^c   Ransohoff, Richard M ^a   Trapp, Bruce D ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^c ELI LILLY AND COMPANY   (United States)

Author keywords

Demyelinating disorders; ICAMs; Inflammation; Integrins; Leukocyte trafficking; LFA 1

Indexed keywords

CELL ADHESION MOLECULE; INTEGRIN; INTERCELLULAR ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 2; INTERCELLULAR ADHESION MOLECULE 3; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1;

ADULT; ARTICLE; CELL ADHESION; CLINICAL ARTICLE; CONTROLLED STUDY; DEMYELINATION; ENCEPHALITIS; HUMAN; HUMAN TISSUE; INFLAMMATION; LEUKOCYTE MIGRATION; LYMPHOCYTIC INFILTRATION; MICROGLIA; MONOCYTE; MULTIPLE SCLEROSIS; PARKINSON DISEASE; PRIORITY JOURNAL;

EID: 0029794737     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005072-199655100-00006     Document Type: Article

References (67)

1. Adams RD, Kubik CS. Morbid anatomy of the demyelinative diseases. Am J Med 1952;12:510-46
2. Raine CS. Demyelinating diseases. In: Davis RL, Robertson DM, eds. Textbook of neuropathology. Baltimore: Williams and Wilkins, 1991:535-620
3. Ransohoff RM, Lehmann P, Tuohy VK. Immunology of multiple sclerosis: New intricacies and new insights. Curr Opin Neurol 1994;7:242-49
4. Gonzalez-Scarano F, Grossman RI, Galetta S, Atlas SW, Silberberg DH. Multiple sclerosis disease activity correlates with gadolinium-enhanced magnetic resonance imaging. Ann Neurol 1987;21:300-306
5. Kermode AG, Thompson AJ, Tofts P et al. Breakdown of the blood-brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis. Brain 1990;113:1477-89
6. Estes ML, Rudick RA, Barnett GH, Ransohoff RM. Stereotactic biopsy of an active multiple sclerosis lesion. Immunocytochemical analysis and neuropathologic correlation with magnetic resonance imaging. Arch Neurol 1990;47:1299-1303
7. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm. Cell 1994;76:301-14
8. Bevilacqua MP. Endothelial-leukocyte adhesion molecules. Annu Rev Immunol 1993;11:767-804
9. Bö L, Mörk S, Kong PA, Nyland H, Pardo CA, Trapp BD. Detection of MHC class II-antigens on macrophages and microglia, but not on astrocytes and endothelia in active multiple sclerosis lesions. J Neuroimmunol 1994;51:135-46
10. Cannella B, Raine CS. Adhesion molecule and cytokine profile of multiple sclerosis lesions. Ann Neurol 1995;37:424-35
11. Paul WE, Seder RA. Lymphocyte responses and cytokines. Cell 1994;76:241-52
12. van Kooyk Y, Figdor CG. Lymphocyte adhesion mediated by integrins. Res Immunol 1993;144:709-22
13. Carlos TM, Harlan JM. Leukocyte-endothelial adhesion molecules. Blood 1994;84:2068-2101
14. Bosman FT. Integrins: Cell adhesives and modulators of cell function. Histochem J 1993;25:469-77
15. Juliano RL, Haskill S. Signal transduction from the extracellular matrix. J Cell Biol 1993:577-85
16. Dustin ML, Springer TA. T-cell receptor cross-linking transiently stimulates adhesiveness through LFA-1. Nature 1989;341:619-24
17. Kurzinger K, Reynolds T, Germain RN, Davignon D, Martz E, Springer TA. A novel lymphocyte function-associated antigen (LFA-1): Cellular distribution, quantitative expression, and structure. J Immunol 1981;127:596-602
18. Marlin SD, Springer TA. Purified intercellular adhesion molecule-1 (ICAM-1) is a ligand for lymphocyte function-associated antigen 1 (LFA-1). Cell 1987;51(5):813-19
19. de Fougerolles AR, Stacker SA, Schwarting R, Springer TA. Characterization of ICAM-2 and evidence for a third counter-receptor for LFA-1. J Exp Med 1991;174:253-67
20. de Fourgerolles AR, Springer TA. Intercellular adhesion molecule 3, a third adhesion counter-receptor for lymphocyte function-associated molecule 1 on resting lymphocytes. J Exp Med 1992;175(1):185-90
21. Pober JS, Gimbrone MA Jr, Lapierre LA, Mendrick DL, Fiers W, Rothlein R, Springer TA. Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor, and immune interferon. J Immunol 1986; 137(6):1893-96
22. Dustin ML, Rothlein R, Bhan AK, Dinarello CA, Springer TA. Induction by IL 1 and interferon-gamma: Tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). J Immunol 1986; 137(1):245-54
23. Dustin ML, Springer TA. Lymphocyte function-associated antigen-1 (LFA-1) interaction with intercellular adhesion molecule-1 (ICAM-1) is one of at least three mechanisms for lymphocyte adhesion to cultured endothelial cells. J Cell Biol 1988;107(1):321-31
24. Shimizu Y, Newman W, Gopal TV, et al. Four molecular pathways of T cell adhesion to endothelial cells: Rolls of LFA-1, VCAM-1, and ELAM-1 and changes in pathway hierarchy under different activation conditions. J Cell Biol 1991;113(5):1203-12
25. Hernandez-Caselles T, Rubio G, Campanero MR, del Pozo MA, Mruo M, Sanchez-Madrid F, Aparicio P. ICAM-3, the third LFA-1 counterreceptor, is a co-stimulatory molecule for both resting and activated T lymphocytes. Eur J Immunol 1993;23:2799-2806
26. de Fourgerolles AR, Qin X, Springer TA. Characterization of the function of intercellular adhesion molecule (ICAM)-3 and comparison with ICAM-1 and ICAM-2 in immune responses. J Exp Med 1994;179:619-29
27. Vazeux R, Hoffman PA, Tomita JK, Dickinson ES, Jasman RL, St. John T, Gallatin WM. Cloning and characterization of a new intercellular adhesion molecule ICAM-R. Nature 1992;360:485-88
28. Cordell JL, Pulford K, Turley H, et al. Cellular distribution of human leucocyte adhesion molecule ICAM-3. J Clin Pathol 1994;47: 143-47
29. Vives J. CD50 is the "signal transducer" ICAM. The Immunologist 1994;2(3):93-98
30. Arroyo AG, Campanero MR, Sanchez-Mateos P, Zapata JM, Ursa MA, del Pozo MA, Sanchez-Madrid F. Induction of tyrosine phosphorylation during ICAM-3 and LFA-I mediated intercellular adhesion, and its regulation by the CD45 tyrosine phosphatase. J Cell Biol 1994;126(5):1277-86
31. Bernard G, Zoccola D, Ticchioni M, Breittmayer JP, Aussel C, Bernard A. Engagement of the CD45 molecule induces homotypic adhesion of human thymocytes through a LFA/1ICAM-3-dependent pathway. J Immunol 1994;152(11):5161-5517
32. Skubitz KM, Ahmed K, Campbell KS, Skubitz AP. CD50 (ICAM-3) is phosphorylated on tyrosine and is associated with tyrosine kinase activity in human neutrophils. J Immunol 1995;154 (6): 2888-95
33. Cannella B, Cross AH, Raine CS. Anti-adhesion molecule therapy in experimental autoimmune encephalomyelitis. J Neuroimmunol 1993;46:1-2
34. Archelos JJ, Jung S, Maurer M, et al. Inhibition of experimental autoimmune encephalomyelitis by an antibody to the intercellular adhesion molecule ICAM-1. Ann Neurol 1993;34:145-54
35. Baron JL, Madri JA, Ruddle NH, Hashim G, Janeway CA, Jr. Surface expression of a4 integrin by CD4 T cells is required for their entry into brain parenchyma. J Exp Med 1993;177:57-68
36. Yednock TA, Cannon C, Fritz LC, Sanchez-Madrid F, Steinman L, Karin N. Prevention of experimental autoimmune encephalomyelitis by antibodies against a4b1 integrin. Nature 1992;356:63-66
37. Kuchroo VK, Martin CA, Greer JM, Ju S-T, Sobel RA, Dorf ME. Cytokines and adhesion molecules contribute to the ability of myelin proteolipid protein-specific T cell clones to mediate experimental allergic encephalomyelitis. J Immunol 1993;151:4371-82
38. Steffen BJ, Butcher EC, Engelhardt B. Evidence for involvement of ICAM-1 and VCAM-1 in lymphocyte interaction with endothelium in experimental autoimmune encephalomyelitis in the central nervous system in the SJL/J mouse. Am J Pathol 1994; 145:1994-99
39. Van Dinther-Janssen ACHM, Horst E, Koopman G, Newmann W, Scheper RJ, Meijer CJLM, Pals ST. The VLA-4/VCAM-1 pathway is involved in lymphocyte adhesion to endothelium in rheumatoid synovium. J Immunol 1991; 147:4207-10
40. Nakamura S, Ohtani S, Watanabe Y, et al. In situ expression of the cell adhesion molecules in inflammatory bowel disease. Lab Invest 1993;69:77-85
41. Van Dinther-Janssen ACHM, Pals ST, Scheper RJ, Meijer CJLM. Role of the CS1 adhesion motif of fibronectin in T cell adhesion to synovial membrane and peripheral lymph node endothelium. Ann Rheum Dis 1993;52:672-76
42. Elices MJ, Tsai V, Strahl D, et al. Expression and functional significance of alternatively spliced CS1 fibronectin in rheumatoid arthritis microvasculature. J Clin Invest 1994;93:405-16
43. Bö L, Dawson TM, Wesselingh S, Mörk S, Choi S, Kong PA, Hanley D, Trapp BD. Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains. Ann Neurol 1994;36: 778-86
44. Sobel RA, Mitchell ME, Fondren G. Intercellular adhesion molecule-1 (ICAM-1) in cellular immune reactions in the human central nervous system. Am J Pathol 1990;136:1309-16
45. Eng RHK, Forrester C, Smith SM, Sobel H. Mycobacterium xenopi infection in a patient with acquired immunodeficiency syndrome. Chest 1984;86:145-47
46. Gerhart DZ, LeVasseur RJ, Broderius MA, Drewes LR. Glucose transporter localization in brain using light and electron immunocytochemistry. J Neurosci Res 1989;22(4):464-72
47. Dore-Duffy P, Newman W, Balabanov R, Lisak RP, Mainolfi E, Rothlein R, Peterson M. Circulating soluble adhesion proteins in cerebrospinal fluid and serum of patients with multiple sclerosis: Correlation with clinical activity. Ann Neurol 1995;37:55-62
48. Rieckmann P, Michel U, Albrecht M, Bruck W, Wockel L, Felgenhauer K. Soluble forms of intercellular adhesion molecule-1 (ICAM-I) block lymphocyte attachment to cerebral endothelial cells. J Neuroimmunol 1995;60:9-15
49. Hartung HP, Michels M, Reiners K, Seeldrayers P, Archelos JJ, Toyka KV. Soluble ICAM-1 serum levels in multiple sclerosis and viral encephalitis. Neurology 1993;43:2331-35
50. Cornford EM, Hyman S, Swartz BE. The human brain GLUT1 glucose transporter: Ultrastructural localization to the blood-brain barrier endothelia. J Cereb Blood Flow Metab 1994;14:106-12
51. Nortamo P, Li R, Renkonen R, Timonen T, Prieto J, Patarroyo M, Gahmberg CG. Expression of human intercellular adhesion molecule-2 is refractory to inflammatory cytokines. Eur J Immunol 1991;21(10):2629-32
52. de Fougerolles A, Diamond MS, Springer TA. Heterogenous glycosylation of ICAM-3 and lack of interaction with MAC-1 and p150,95. Eur J Immunol 1995;25(4):1008-12
53. EI-Gabalawy H, Gallatin M, Vazeux R, Peterman G, Wilkins J. Expression of ICAM-R (ICAM-3), a novel counter-receptor for LFA-1, in rheumatoid and nonrheumatoid synovium. Arthritis Rheum 1994;37:846-54
54. Fawcett J, Holness CL, Needham LA, Turley H, Gatter KC, Mason DY, Simmons DLk. Molecular cloning of ICAM-3, a third ligand for LFA-1, constitutively expressed on resting leukocytes. Nature 1992;360:481-84
55. Holness CL, Simmons DL. Molecular cloning of CD68, a human macrophage marker related to lysosomal glycoproteins. Blood 1993;81:1607-13
56. del Pozo M, Pulido R, Munoz C, Alvarez V, Humbria A, Campanero MR, Sanchez-Madrid F. Regulation of ICAM-3 (CD50) membrane expression on human neutrophils through a proteolytic shedding mechanism. Eur J Immunol 1994;24(11):2586-94
57. 1. J Immunol 1995;154(4):1951-55
58. Wucherpfennig KW, Weiner HL, Hafler DA. T-cell recognition of myelin basic protein. Immunol Today 1991;12:277-82
59. Hickey WF. Migration of hematogenous cells through the blood-brain barrier and the initiation of CNS inflammation. Brain Pathol 1991;1:97-105
60. Utz U, McFarland HE The role of T cells in multiple sclerosis: Implications for therapies targeting the T cell receptor. J Neuropathol Exp Neurol 1994;53:351-58
61. van Seventer GA, Newman W, Shimizu Y, et al. Analysis of T cell stimulation by superantigen plus major histocompatibility complex class II molecules or by CD3 monoclonal antibody: Costimulation by purified adhesion ligands VCAM-1, ICAM-1, but not ELAM-1. J Exp Med 1991;174:901-13
62. Rudd CE, Janssen O, Cai YC, da Silva AJ, Raab M, Prasad KV. 2-step TCR Zeta/CD3-CD4 and CD28 signaling in T cells: SH2/ SH3 domain, protein-tyrosine and lipid kinases. (Review). Immunol Today 1994; 15:225-34
63. Damle NK, Aruffo A. Vascular cell adhesion molecule 1 induces T-cell antigen receptor-dependent activation of CD4+ lymphocytes. Proc Natl Acad Sci USA 1988;15:6403-7
64. Cannella B, Raine CS. The VCAM-1/VLA-4 pathway is involved in chronic lesion expression in multiple sclerosis (MS). (Abstract) J Neuropathol Exp Neurol 1993;524:311
65. Williams K, Ulvestad E, Antel JP. B7/BB-1 expression on adult human microglia studies in vitro and in situ. Eur J Immunol 1994;24:3031-37
66. Landis RC, McDowall A, Holness CLL, Littler AJ, Simmons DL, Hogg N. Involvement of the "I" domain of LFA-1 in selective binding to ligands ICAM-1 and ICAM-3. J Cell Biol 1994;126: 529-37
67. Campanero MR, del Pozo MA, Arroyo AG, et al. ICAM-3 interacts with LFA-1 and regulates the LFA-1/ICAM-1 cell adhesion pathway. J Cell Biol 1993;123:1007-16